FDA Approves Merck’s WELIREG for Advanced PPGL in Patients 12 and Older
FDA Approves Merck’s WELIREG® (belzutifan) for Advanced Pheochromocytoma and Paraganglioma in Patients 12 Years and Older, Marking a New Era in Treatment of Rare Neuroendocrine Tumors Merck, known as MSD…
AbbVie and ADARx Pharmaceuticals Forge Collaboration and Licensing Deal to Advance Next-Gen siRNA Therapies Across Diverse Disease Areas
AbbVie and ADARx Partner to Advance Next-Generation siRNA Therapies Across Neuroscience, Immunology, and Oncology in Multibillion-Dollar Collaboration AbbVie, a global biopharmaceutical leader known for its portfolio of therapies in immunology,…
FDA Approves EMRELIS for Advanced NSCLC With High c-Met Expression
AbbVie Gains First Solid Tumor FDA Approval With EMRELIS™ for High c-Met Overexpressing Advanced NSCLC AbbVie has achieved a key milestone in its oncology pipeline with the announcement that the…
Novo Nordisk, Septerna Partner on Oral Obesity, Cardiometabolic Drugs
Novo Nordisk and Septerna Forge $2.2 Billion Global Alliance to Develop Oral Small Molecule Therapies for Obesity and Cardiometabolic Diseases In a significant expansion of its research and development pipeline,…
WHO Announces Members of Surgical Sub-Group for Caesarean Section Guidelines
WHO Establishes Expert Surgical Sub-Group to Develop Global Guidelines for Caesarean Section Practices Caesarean section, often referred to as C-section, has become the most common major abdominal surgery performed across…
Sarepta’s ELEVIDYS Gene Therapy Approved in Japan for Duchenne Muscular Dystrophy
Sarepta’s ELEVIDYS Gene Therapy Gains Landmark Approval in Japan for Duchenne Muscular Dystrophy Sarepta Therapeutics, a biotechnology leader in precision genetic medicine for rare diseases, has announced a significant regulatory…
Legend Biotech Announces Q1 2025 Financial Results and Key Developments
Legend Biotech Reports Strong First Quarter 2025 Performance and Strategic Milestones as CARVYKTI® Continues to Lead in Multiple Myeloma Legend Biotech Corporation, a global frontrunner in the field of cell…
WuXi Biologics Ireland Advances Sustainability Through Strategic Innovation
WuXi Biologics Ireland: Pioneering Sustainable Biomanufacturing Through Purpose-Driven Innovation In an era where sustainability has become a defining metric of corporate integrity and resilience, WuXi Biologics Ireland stands out as…
UCB Showcases gMG Data at MGFA Conference, Underscoring Treatment Commitment
UCB Highlights Robust Data on Generalized Myasthenia Gravis Therapies at 15th MGFA International Conference, Reinforcing Commitment to Patient-Centered Innovation UCB,a global biopharmaceutical leader specializing in immunology and neurology, has announced…
CMS Set for Third Round of Price Negotiations as Trump Sharpens Focus on Drug Costs
CMS Prepares Third Cycle of Drug Price Negotiations Under IRA as Trump Administration Revives Push to Lower U.S. Prescription Costs In a move that signals the growing momentum of federal…
Bayer Reaffirms 2025 Outlook Following Strong Start to the Year
Bayer Reaffirms 2025 Outlook Following Robust First-Quarter Performance, Showcases Strength in Pharmaceuticals and Strategic Advancements in Crop Science Bayer AG has started 2025 with a strong operational footing, underscoring confidence…
Aetna, Partners Unite to Bolster Direct Care Workforce in IL, LA, NC
Aetna, National Alliance for Care at Home, and MissionCare Collective Partner to Strengthen the Direct Care Workforce in Illinois, Louisiana, and North Carolina In a bold and strategic move to…